Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $143,846 - $181,258
-2,331 Reduced 43.91%
2,977 $226,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $68,587 - $92,446
990 Added 22.93%
5,308 $367,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $229,169 - $265,538
-2,815 Reduced 39.46%
4,318 $407,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $260,726 - $296,714
3,511 Added 96.94%
7,133 $590,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $725,072 - $928,263
-10,616 Reduced 74.56%
3,622 $270,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $1.17 Million - $1.53 Million
14,238 New
14,238 $1.18 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $1.12 Million - $1.43 Million
-15,652 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $1 Million - $1.3 Million
-14,889 Reduced 48.75%
15,652 $1.25 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.76 Million - $2.35 Million
30,541 New
30,541 $2.11 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $1.82 Million - $2.23 Million
-39,160 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $2.86 Million - $3.64 Million
-62,680 Reduced 61.55%
39,160 $6.82 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $1.15 Million - $1.39 Million
27,030 Added 36.13%
101,840 $14.8 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $172,933 - $220,642
-4,650 Reduced 5.85%
74,810 $10.4 Million
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $1.13 Million - $1.32 Million
33,570 Added 73.15%
79,460 $8.96 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $1.67 Million - $1.78 Million
45,890
45,890 $5.02 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.